Low T Center Endorses the Joint FDA Committee Meeting on Testosterone
Low T Center endorses the recommendations of the joint FDA committee meeting in Hyattsville, Maryland, earlier this week. The FDA convened the meeting to assess the proper patient population for testosterone therapy (TRT), as well as to assess potential cardiovascular risk associated with TRT. Examining recent claims from studies that TRT affects cardiovascular health, the […]